Concepedia

Roberto Kuri

RK

Statistics

Publications

2

Citations

641

H-Index

2

Active since

2009

Affiliations

Tisch Hospital(Current)

Roberto Kuri is an author at Tisch Hospital specializing in oncology, medicine, and chemotherapy.

Publications per year

2009–2020

2

Publications

2

Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

Michiel S. van der Heijden, Matthew D. Galsky, Yohann Loriot et al. · The Lancet Oncology · 2020 · 498 citations · Full text

, , +14

Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer: a prospective analysis

Óscar Arrieta, David Saavedra-Pérez, Roberto Kuri et al. · BMC Cancer · 2009 · 143 citations · Full text

, , +15

1–2 of 2